Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment

HBV vaccination is recommend for hemodialysis patients, but only 50–60% of the patients show seroconversion. vaccine-induced generation reactive T and B cells could be detected regardless their capacity to mount a serological response, indicating that without seroconversion are potentially protected by HBV-reactive cell pool.